4th Biennial World Summit of Brain Tumour Patient Advocates

9.-12. Oktober 2019
Bethesda, MD, USA

Teilnehmer: Dr. Irina Odnoletkova, MBA, VP Health Technology Assessment

 

Festival of Biologics

15.-17. Oktober 2019
Basel, Schweiz

Teilnehmer:
Dr. Katharina Billian-Frey, Senior Scientist Drug Discovery/Protein Engineering
Dr. Oliver Hill, VP Drug Discovery/Lead Optimization

Präsentation am 16. Oktober um 12:05 Uhr:
"HERA-CD40L: A unique hexavalent CD40 agonist for cancer immunotherapy"

 

ISPOR Europe 2019

2.-6. November 2019
Kopenhagen, Dänemark

Teilnehmer: Dr. Irina Odnoletkova, MBA, VP Health Technology Assessment

Poster-Präsentation am 4. November, 15:30-19:00 Uhr (Poster Author Discussion Hour: 18:00-19:00 Uhr):
"Therapeutic Benefit of Orphan Drugs in Oncology: Evidence at the Point of European Marketing Authorisation"

 

BIO-Europe 2019

11.-13. November 2019
Hamburg

Teilnehmer:
Dr. Jürgen Gamer, VP Business Development
Dr. Niclas Kneisel, Alliance Manager

 

11th Annual PEGS Europe

18.-22. November 2019
Lissabon, Portugal

Teilnehmer:
Dr. Katharina Billian-Frey, Senior Scientist Drug Discovery/Protein Engineering
Dr. Oliver Hill, VP Drug Discovery/Lead Optimization

Präsentation von Dr. Hill am 22. November um 14:35 Uhr:
"
HERA-GITRL: A Unique Hexavalent GITR Agonist for Cancer Immunotherapy"

 

SNO 2019 Annual Meeting

22.-24. November 2019
Phoenix, AZ, USA

Teilnehmer: Dr. Jürgen Gamer, VP Business Development

 

8th Annual PREDiCT: Tumour Models London Summit

4.-6. Dezember 2019
London, UK

Teilnehmer: Dr. Mauricio Redondo-Müller, Director Preclinical Development

 

19th Annual PepTalk

20.-24. Januar 2020
San Diego, CA, USA

Teilnehmer: Dr. Katharina Billian-Frey, Senior Scientist Drug Discovery/Protein Engineering

 

AACR Annual Meeting 2020

24.-29. April 2020
San Diego, CA, USA

Teilnehmer:
Dr. Christian Gieffers, VP Protein Chemistry
Dr. Christian Merz, Head of Cellular Analytics
Dr. Meinolf Thiemann, Director Protein Analytics